PAPER Ueda T, Inden M, Ito T, Kurita H, Hozumi I
SEARCH RESULTS
1329 RESULTS
PAPER Mitsuhashi K, Ito D, Mashima K, Oyama M, Takahashi S, Suzuki N
Author Correction: De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Sci Rep. 2020 May 26;10(1):8746. PubMed: 32457403PAPER Bugallo R, Marlin E, Baltanás A, Toledo E, Ferrero R, Vinueza-Gavilanes R, Larrea L, Arrasate M, Aragón T
Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis.
Cell Death Dis. 2020 May 26;11(5):397. PubMed: 32457286PAPER Dutta K, Thammisetty SS, Boutej H, Bareil C, Julien JP
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.
J Neurosci. 2020 Jun 24;40(26):5137-5154. Epub 2020 May 26 PubMed: 32457070PAPER Barp A, Gerardi F, Lizio A, Sansone VA, Lunetta C
Emerging Drugs for the Treatment of Amyotrophic Lateral Sclerosis: A Focus on Recent Phase 2 Trials.
Expert Opin Emerg Drugs. 2020 Jun;25(2):145-164. Epub 2020 May 27 PubMed: 32456491PAPER Obrenovich M, Jaworski H, Tadimalla T, Mistry A, Sykes L, Perry G, Bonomo RA
The Role of the Microbiota-Gut-Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases.
Microorganisms. 2020 May 23;8(5) PubMed: 32456229PAPER Bonafede R, Turano E, Scambi I, Busato A, Bontempi P, Virla F, Schiaffino L, Marzola P, Bonetti B, Mariotti R
ASC-Exosomes Ameliorate the Disease Progression in SOD1(G93A) Murine Model Underlining Their Potential Therapeutic Use in Human ALS.
Int J Mol Sci. 2020 May 21;21(10) PubMed: 32455791PAPER Trojsi F, D'Alvano G, Bonavita S, Tedeschi G
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
Int J Mol Sci. 2020 May 21;21(10) PubMed: 32455692PAPER Sharma A, Weber D, Raupbach J, Dakal TC, Fließbach K, Ramirez A, Grune T, Wüllner U
Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease.
Redox Biol. 2020 Jul;34:101546. Epub 2020 May 18 PubMed: 32460130PAPER Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P
Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges.
J Med Chem. 2020 Oct 8;63(19):10705-10725. Epub 2020 Jun 10 PubMed: 32459966PAPER Chen J, Yin B, Wang W, Sun H
Effects of Disulfide Bonds on Binding of Inhibitors to β-Amyloid Cleaving Enzyme 1 Decoded by Multiple Replica Accelerated Molecular Dynamics Simulations.
ACS Chem Neurosci. 2020 Jun 17;11(12):1811-1826. Epub 2020 Jun 8 PubMed: 32459964PAPER Pusceddu MM, Del Bas JM
The role of the gut microbiota in the pathophysiology of mental and neurological disorders.
Psychiatr Genet. 2020 Aug;30(4):87-100. PubMed: 32459708PAPER Thomas NW, Beattie Z, Marcoe J, Wright K, Sharma N, Mattek N, Dodge H, Wild K, Kaye J
An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study.
JMIR Res Protoc. 2020 May 27;9(5):e17603. PubMed: 32459184PAPER Krishna-K K, Baby N, Raghuraman R, Navakkode S, Behnisch T, Sajikumar S
Regulation of aberrant proteasome activity re-establishes plasticity and long-term memory in an animal model of Alzheimer's disease.
FASEB J. 2020 Jul;34(7):9466-9479. Epub 2020 May 27 PubMed: 32459037PAPER Wang XZ, Du J, Xiao NN, Zhang Y, Fei L, LaCoste JD, Huang Z, Wang Q, Wang XR, Ding B
Driving force to detect Alzheimer's disease biomarkers: application of a thioflavine T@Er-MOF ratiometric fluorescent sensor for smart detection of presenilin 1, amyloid β-protein and acetylcholine.
Analyst. 2020 Jul 7;145(13):4646-4663. Epub 2020 May 27 PubMed: 32458857Current Filters
- Date Range : Apr 2020 to May 2020 x